Biovista has been selected as one of the top-20 AI Drug Development companies in a recent article in Forbes View the article here: https://www.forbes.com/sites/yiannismouratidis/2018/12/16/the-rising-star-companies-in-ai-drug-development/
Find genes and pathways related to Duchenne and PDE5. Use Vizit live graph to explore Duchenne Muscular Dystrophy. Explore the live graph.
Could Multiple Sclerosis be linked to the Microbiome? Use Biovista Vizit, a brainstorming tool for scientists. Explore the live graph.
“Live graph” of PPARgamma associated with common drugs and two major diseases, Alzheimer’s and Diabetes. Explore the live graph.
By Andreas Persidis, CEO Biovista Inc. The increasing importance of predicting AEs & the role of Augmented Intelligence Case in point: precision medicine and drug repurposing. The approval of a drug has to date been the result of the careful assessment of its benefit-to-risk ratio. In this analysis, the benefit (efficacy) side of the equation … Read More